Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
11.9%Depreciation and Amortization Margin
VS
Market
Sector
Industry
History
$ 9.16Close
$ 4.26 - $ 11.97 52-Week Range
Ticker Information
Ticker
EBSCompany Name
EMERGENT BIOSOLUTIONS INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NYSEEMERGENT BIOSOLUTIONS INC - Depreciation and Amortization Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
EBS - DepAmor % Historical data
| Date | Depreciation, Amortization & Accretion | Depreciation and Amortization Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 101.3M | 11.9% | $ 851.6M |
| 3/31/2025 | $ 106.3M | 11.01% | $ 965.4M |
| 12/31/2024 | $ 108.8M | 10.43% | $ 1.04B |
| 9/30/2024 | $ 112.4M | 9.99% | $ 1.13B |
| 6/30/2024 | $ 114M | 10.34% | $ 1.1B |
| 3/31/2024 | $ 118.4M | 9.99% | $ 1.19B |
| 12/31/2023 | $ 125.1M | 11.92% | $ 1.05B |
| 9/30/2023 | $ 131.2M | 11.89% | $ 1.1B |
| 6/30/2023 | $ 135.4M | 12.61% | $ 1.07B |
| 3/31/2023 | $ 147M | 15.02% | $ 978.5M |
Key Performance Insights, Last 5 Years
- EMERGENT BIOSOLUTIONS INC's latest trailing twelve months (TTM) DepAmor % stands at 8.52%.
- Over the past 5 years, EMERGENT BIOSOLUTIONS INC's average DepAmor % has been 9.83%.
- The median DepAmor % for EMERGENT BIOSOLUTIONS INC during this period was 9.99%
- EMERGENT BIOSOLUTIONS INC reached its highest DepAmor % over the past 5 years at 15.02%.
- The lowest DepAmor % recorded by EMERGENT BIOSOLUTIONS INC in the same timeframe 6.74%
EMERGENT BIOSOLUTIONS INC's DepAmor % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
DepAmor % Benchmarks
Similar metrics to Revenues:
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation, Amortization & Accretion - [Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.
Definition of Depreciation and Amortization Margin
[Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].DepAmor / Revenues
(=) DepAmor % DepAmor % for EMERGENT BIOSOLUTIONS INC is calculated as follows: DepAmor [ $ 113.5M ] / Revenues [ $ 1.33B ]
(=) DepAmor % [ 8.52% ] EBS - Depreciation and Amortization Margin, Last 5 years
6.74%
Minimum
Mar 31, 2021
15.02%
Maximum
Mar 31, 2023
9.83%
Average
9.99%
Median
DepAmor % Benchmark AnalysisMarket
The chart above depicts the distribution of DepAmor % for companies in the Total Stock Market. The average DepAmor % of the companies is 5.85% with a standard deviation of 5.13%.
The following table provides additional summary stats:
DepAmor % in the Market:
| filtered constituents | 3.32K |
|---|---|
| min | -6.41% |
| max | 22.52% |
| average | 5.85% |
| median | 4.2% |
| std | 5.13% |